News Edwards Lifesciences Corporation Swiss Exchange

Equities

EW

US28176E1082

Market Closed - Swiss Exchange Other stock markets 09:05:35 27/06/2019 pm IST			5-day change	1st Jan Change
60.6 ^CHF	-1.45%		-.--%	-.--%

20/06	Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	MT
17/06	Edwards Lifesciences Corporation Announces Executive Changes	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	21/06	MT
Edwards Lifesciences Corporation Announces Executive Changes	18/06	CI
Wolfe Research Adjusts Price Target on Edwards Lifesciences to $70 From $75	17/06	MT
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR	05/06	BU
Edwards Lifesciences Announces Results from Analysis of Data from Partner Trials Examining Outcomes of Transcatheter Aortic Valve Replacement Patients with Small Annulus	05/06	CI
Transcript : Edwards Lifesciences Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:30 AM	05/06
Transcript : Edwards Lifesciences Corporation Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 12:00 PM	04/06
Sector Update: Health Care Stocks Steady Premarket Monday	03/06	MT
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	03/06	MT
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	03/06	RE
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion	03/06	MT
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader	03/06	PR
Edwards Lifesciences to Sell Critical Care to BD	03/06	BU
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.	03/06	CI
Edwards Lifesciences : Charter of the Audit Committee	28/05	PU
Some of the biggest splits in Corporate America	23/05	RE
Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98	22/05	MT
Edwards Lifesciences : First Quarter 2024 Fact Sheet	15/05	PU
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	14/05	MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	14/05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 08:55 pm IST